Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Elevar Therapeutics
.
Show all posts
Showing posts with label
Elevar Therapeutics
.
Show all posts
Monday, June 29, 2026
Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment
›
Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevat...
›
Home
View web version
